Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Shanghai Stock Exchange  >  Kangmei Pharmaceutical Co., Ltd.    600518   CNE0000017M1

KANGMEI PHARMACEUTICAL CO., LTD.

(600518)
  Report
SummaryChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Kangmei Pharmaceutical Co., Ltd. : annual earnings release

06/15/2020 | 09:15am EST

The company will report its earnings for FY 2019 on 06/18/2020. Generally, the company reports earnings worse than estimates. In recent months, the analysts from Standard & Poor's consensus have revised their EPS estimates downward.


© MarketScreener.com 2020
All news about KANGMEI PHARMACEUTICAL CO., LTD.
2020MARKET CHATTER : GF Securities to Rejig Banking Operations After Client's Nearly..
MT
2020Prices of China's Traditional Medicinal Materials Rise Tuesday
MT
2020China vows 'zero tolerance' towards illegal market behaviour
RE
2020KANGMEI PHARMACEUTICAL CO., LTD. : annual earnings release
2020China's securities watchdog pledges to clean up financial markets
RE
2019China's Kangmei Pharma sinks by daily limit as watchdog accuses it of fraud
RE
2019Chinese firms' missing $6 billion tests regulators' resolve
RE
2019As China pushes traditional medicine globally, illegal wildlife trade flouris..
RE
More news
Financials
Sales 2019 11 446 M 1 770 M 1 770 M
Net income 2019 -4 661 M -721 M -721 M
Net Debt 2019 31 913 M 4 934 M 4 934 M
P/E ratio 2019 -3,77x
Yield 2019 -
Capitalization 11 788 M 1 818 M 1 823 M
EV / Sales 2018 4,67x
EV / Sales 2019 4,41x
Nbr of Employees 9 209
Free-Float 51,2%
Chart KANGMEI PHARMACEUTICAL CO., LTD.
Duration : Period :
Kangmei Pharmaceutical Co., Ltd. Technical Analysis Chart | 600518 | CNE0000017M1 | MarketScreener
Technical analysis trends KANGMEI PHARMACEUTICAL CO., LTD.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Managers and Directors
NameTitle
Guo Wei Liu General Manager
Xing Gu Ma Chairman
Jing Ke Chairman-Supervisory Board
Jin Cheng Wan Chief Financial Officer & Director
Zhen Ping Jiang Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
KANGMEI PHARMACEUTICAL CO., LTD.-12.69%1 818
JOHNSON & JOHNSON6.67%441 951
ROCHE HOLDING AG3.62%309 011
NOVARTIS AG0.20%212 810
PFIZER INC.-1.55%201 436
MERCK & CO., INC.-5.78%194 990